On CNBC's Mad Money, Jim Cramer said that he believes in L Brands Inc LB and that he finds it to be a superior retailer. In the long-term it should do well, thinks Cramer, but currently investors are getting out of the U.S. stocks and they are buying international stocks.
Cramer believes that Revance Therapeutics Inc RVNC could be a game-changer. He added that speculative stocks are not doing well currently, but he is watching Revance closely.
Among the immunotherapy stocks, bluebird bio Inc BLUE remains Cramer's favorite. It is a first-rate company and Cramer likes it.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in